Search the Newsreel

Is Teleflex (TFX) A Bargain Following FDA Approval And The $1.5b OEM Sale?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Teleflex (TFX) is drawing fresh investor attention after two closely timed moves. The company secured FDA approval for its EZPLAZ Freeze Dried Plasma …

Teleflex (TFX) Q2 Earnings Report Preview: What To Look For

Teleflex Closes $1.5B OEM Sale; Business Rebrands as Ingenyx

Teleflex has completed the divestiture of its OEM business to Montagu and Kohlberg for $1.5 billion in cash, with net proceeds estimated at $1.25 billion. The OEM business will now operate independently under the new brand Ingenyx, aiming to accelerate innovation and expand its …

Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators

INGENYX, formerly Teleflex Medical OEM, has launched as an independent company after its acquisition by Montagu and Kohlberg. The company aims to accelerate innovation in the MedTech industry by expanding engineering capabilities and strengthening customer collaboration, building on over 40 years of experience in …

Teleflex stock hits 52-week high at $139.77

Teleflex Inc. (TFX) stock has reached a new 52-week high of $139.77, reflecting a 34% surge over the past six months and a 19.24% increase over the last year. InvestingPro analysis indicates the stock is currently undervalued, and the company has consistently paid dividends …

Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion

Teleflex Incorporated has completed the divestiture of its OEM business to Montagu and Kohlberg for $1.5 billion in cash. This strategic move sharpens Teleflex's focus on its core commercial businesses and enhances financial flexibility. The company plans to use the net proceeds, estimated at …

How FDA Approval of First Freeze Dried Plasma Platform Will Impact Teleflex (TFX) Investors

Teleflex (TFX) recently received FDA approval for EZPLAZ Freeze Dried Plasma, the first FDA-licensed freeze-dried plasma for adult transfusions, which could reshape its investment narrative. This approval, alongside other innovations like the BIOMAG III trial, signifies Teleflex's shift towards differentiated, higher-value medical devices. However, …

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 32.3% Revenue Growth Amidst a Complex Valuation

Teleflex Incorporated $TFX Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company sold 18,559 shares of Teleflex Incorporated ($TFX) in Q1, reducing its stake by 8.4% to 202,524 shares valued at $24.2 million. Institutional investors and hedge funds collectively own 95.62% of the company. Teleflex currently holds a consensus "Hold" rating …

Teleflex Incorporated $TFX Shares Sold by Sei Investments Co.

Sei Investments Co. significantly reduced its stake in Teleflex Incorporated by 38.9% in the first quarter, selling 46,479 shares and retaining 73,065 shares. Despite this, Teleflex surpassed quarterly earnings and revenue expectations and declared a quarterly dividend of $0.34. Analysts currently hold a "Hold" …

Needham raises Teleflex stock price target on FDA plasma approval

Needham has increased its price target for Teleflex (NYSE:TFX) to $159 from $147, maintaining a Buy rating, following FDA approval of the company's EZPLAZ Freeze Dried Plasma product. The stock is currently trading at $132.30, and InvestingPro suggests it is undervalued. The approval of …

Needham Raises Price Target on Teleflex to $159 From $147, Keeps Buy Rating

Needham has increased its price target for Teleflex (TFX) to $159 from $147, while maintaining a Buy rating on the stock. This adjustment reflects Needham's continued positive outlook on the company's financial prospects and market position.

Teleflex's FDA BLA Approval: Could Freeze-Dried Plasma Change Trauma Care Forever?

(RTTNews) - Teleflex Incorporated (TFX), a provider of medical technologies, announced that the U.S. FDA has approved its BLA for EZPLAZ Freeze Dried Plasma (FDP). EZPLAZ FDP is indicated for transfusion in adults with bleeding-related conditions requiring replacement of plasma coagulation factors, including uncontrolled …

Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma

Teleflex Incorporated has received FDA Biologics License Application (BLA) approval for EZPLAZ™ Freeze Dried Plasma (FDP), marking the first FDA-approved freeze-dried plasma product. This approval addresses critical logistical challenges in providing plasma for bleeding-related conditions, especially in emergency and battlefield settings, enabling easier storage …

Teleflex receives FDA approval for freeze dried plasma product By Investing.com

Teleflex Incorporated announced FDA approval for its EZPLAZ Freeze Dried Plasma, the first freeze-dried plasma product licensed by the FDA. This product is intended for adults with bleeding conditions requiring plasma coagulation factors when other plasma products are unavailable. EZPLAZ FDP offers logistical advantages …

Teleflex Number of Employees 2026 | Employee Count & Headcount Data

Teleflex, Inc. (TFX) had approximately 15,496 employees worldwide as of March 2026, marking a 3.2% growth from 2023. The company, headquartered in Wayne, Pennsylvania, is actively hiring with 295 job postings in 2026, though hiring velocity has declined. Its workforce is primarily concentrated in …

Irenic Capital Management LP Takes $104.06 Million Position in Teleflex Incorporated $TFX

Irenic Capital Management LP has acquired a new position in Teleflex Incorporated, purchasing 870,000 shares valued at approximately $104.06 million, making it their third-largest holding. This move contributes to Teleflex's high institutional ownership of 95.62%, with other major investors also increasing their stakes. Despite …

Dimensional Fund Advisors LP Has $119.26 Million Stock Holdings in Teleflex Incorporated $TFX

Dimensional Fund Advisors LP reduced its stake in Teleflex Incorporated by 20.3% in the first quarter, now holding 997,144 shares valued at $119.26 million. Several other institutional investors also adjusted their holdings, with some acquiring new positions and others increasing existing ones. Teleflex reported …

Investor Relations

Teleflex is a global provider of medical technologies focused on improving health and quality of life through purpose-driven innovation. The company's diverse portfolio includes solutions in various medical fields, and it is known for brands like Arrow, Deknatel, and UroLift. Teleflex encourages investors to …

TFX|Teleflex Inc|Price:131.080|Chg%:-1.020

This article provides a comprehensive stock analysis of Teleflex Inc (TFX) by TradingKey, highlighting its "Fairly Valued" status and high institutional ownership. Despite a recent turn to loss, the company is noted for its high and stable dividend payout. Analysts currently rate the stock …

California Public Employees Retirement System Has $6.79 Million Stock Holdings in Teleflex Incorporated $TFX

The California Public Employees' Retirement System (CalPERS) recently reduced its stake in Teleflex Incorporated (NYSE:TFX) by 30.6% in the first quarter, now holding 56,778 shares valued at approximately $6.79 million. Despite this reduction, other institutional investors like AQR Capital Management LLC and Norges Bank …

Arrowstreet Capital Limited Partnership Lowers Stock Position in Teleflex Incorporated $TFX

Arrowstreet Capital Limited Partnership has reduced its stake in Teleflex Incorporated (NYSE:TFX) by 14.8% during the first quarter, selling over 111,000 shares. Despite this, other institutional investors like AQR Capital Management LLC and Norges Bank increased their holdings in the medical technology company. Analyst …

TFX|Teleflex Inc|Price:132.100|

Teleflex Inc

How Investors Are Reacting To Teleflex (TFX) Winning Premier Deal For Vascular Access Products

Teleflex Incorporated has secured a national group purchasing agreement with Premier, Inc. for its Arrow brand vascular access portfolio, which could expand its presence in hospital systems. This deal, along with the recent BIOTRONIK Vascular Intervention acquisition, emphasizes Teleflex's focus on vascular access and …

Teleflex Inc. stock underperforms Thursday when compared to competitors

Teleflex Inc. (TFX) shares dropped by 2.70% on Thursday, closing at $131.16, in a trading session where both the S&P 500 and Dow Jones Industrial Average also experienced declines. This marks the second consecutive day of losses for the stock. Despite the broad market …

Press Release: Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

Teleflex (NYSE: TFX) will announce its financial results for the second quarter of 2026 before the market opens on Thursday, August 1, 2026. The company will host a conference call at 8:00 a.m. ET

Teleflex to host Q2 2026 earnings conference call on August 6

Teleflex Incorporated will host a conference call on August 6, 2026, at 8:00 a.m. Eastern Time to discuss its second-quarter 2026 financial results and provide operational updates. Investors and interested parties can access the live audio webcast through the company's website or pre-register for …

Walleye Capital LLC Trims Stock Position in Teleflex Incorporated $TFX

Walleye Capital LLC significantly reduced its stake in Teleflex Incorporated by 89.4% in the first quarter, selling over 285,000 shares. Despite this, Teleflex reported better-than-expected earnings and pays a quarterly dividend, though Wall Street analysts generally hold a "Hold" rating on the stock with …

Teleflex (TFX) Expected to Release Quarterly Earnings on Thursday

Teleflex sets August 6 webcast for results and operations update

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of "Hold" from Brokerages

Teleflex Incorporated (NYSE:TFX) has received a consensus "Hold" rating from eleven brokerages, with an average 12-month price target of $148.00. The medical technology company recently exceeded quarterly earnings expectations, reporting EPS of $1.39 and revenue of $548.3 million, a 32.3% year-over-year increase. Institutional investors …

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Teleflex Incorporated has secured a national group purchasing agreement with Premier, Inc. for central venous access products, effective July 1, 2026. This agreement allows Premier members access to special pricing and terms for Teleflex's vascular access solutions, including short-term central venous catheters, arterial catheter …

Bessemer Group Inc. Grows Stake in Teleflex Incorporated $TFX

Bessemer Group Inc. significantly increased its stake in Teleflex Incorporated during the first quarter, now owning 47,798 shares valued at approximately $5.7 million. This move is part of broader institutional investor activity, with these entities holding 95.62% of Teleflex shares. The company recently reported …

TFX4991347 Bond Profile — Key Metrics

This article provides a detailed profile of the Teleflex Incorporated 4.25% 01-JUN-2028 bond, TFX4991347. It highlights key bond metrics such as issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. Additionally, it offers a brief company description of Teleflex, …

Is Teleflex (TFX) Still Below Fair Value As Its Recovery Story Rebuilds?

Teleflex (TFX) stock is attracting investor interest following mixed long-term returns but a positive 1-year total return, though it remains below its fair value estimate and analyst target. While the company's focus on portfolio optimization could unlock value, concerns remain regarding UroLift weakness and …

Teleflex Is Maintained at Neutral by Mizuho

Mizuho has maintained its Neutral rating on Teleflex (NYSE: TFX) stock. This indicates that the analyst firm views the stock as neither an outperform nor underperform. The full article content was not provided, so details on the underlying analysis are unavailable.